TGA tightens Ozempic advice (again) as global shortage bites
Dr Gary Deed said ongoing supply issues were "frustrating" GPs and patients.
The TGA is once again urging doctors against initiating patients on semaglutide, less than three months after relaxing its prescribing advice, as limited supply struggles to keep up with surging demand.
On Thursday, the regulator said supply constraints for all strengths of semaglutide (Ozempic) would persist for the rest of the year and throughout 2024.
